The effect of increase in NT-proBNP on the efficacy and safety of a rapid up-titration of guideline-directed medical therapy in patients with low predischarge NT-proBNP

9 May 2026 (10:30 - 11:00)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Judit Papp

Central Hospital Of Northern Pest Military Hospital, Budapest (Hungary)

3 More presentations in this session

Presentation thumbnail

Healthcare utilisation and clinical outcomes following implementation of an accelerated treatment pathway for patients with HFrEF.

Mrs M. Copley (Auckland, NZ)

Abstract Slides Video

Presentation thumbnail

The prognostic role of regular NT-proBNP measurement after a rapid-up titration programme of guideline-directed medical therapy in heart failure: essential or superfluous?

Doctor B. Muk (Budapest, HU)

Abstract Slides Video

Presentation thumbnail

Patient self-adjustment of diuretics in heart failure: evidence gaps despite guideline recommendations - insights from a scoping review

Ms E. O'Donoghue (Dublin, IE)

Abstract Slides Video

Access the full session

Session thumbnail

Optimisation strategies in heart failure treatment

The Event

Event poster

Heart Failure 2026

9 May 2026 10:30 CET

You may be interested in

Congress Presentation

The prognostic role of regular NT-proBNP measurement after a rapid-up titration programme of guideline-directed medical therapy in heart failure: essential or superfluous?

Congress Presentation

Rapid up-titration of guideline-directed medical therapy in real-world clinical practice: initial experience of a heart failure outpatient clinic

Congress Presentation

Comparison of the effect of the rapid up-titration programme and the standard care on therapy optimisation at a heart failure outpatient clinic in real-world clinical practice

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources